T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments.
Am J Hematol
; 99(3): 494-496, 2024 03.
Article
in En
| MEDLINE
| ID: mdl-38240336
ABSTRACT
Survival remains poor for T-cell prolymphocytic leukemia, though treatment in recent years, associated with access to novel therapies, and management at academic medical centers is associated with improved outcomes. There remains a critical need to improve the available treatment options for this population, and access to specialized academic medical centers, comprehensive supportive care, clinical trials, and early palliative care remains essential for T-PLL patients.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Prolymphocytic, T-Cell
/
Hematopoietic Stem Cell Transplantation
Type of study:
Screening_studies
Limits:
Humans
Language:
En
Journal:
Am J Hematol
Year:
2024
Document type:
Article
Affiliation country: